LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States.
Excellent balance sheet with proven track record.
Share Price & News
How has LHC Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: LHCG's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: LHCG exceeded the US Healthcare industry which returned 21.5% over the past year.
Return vs Market: LHCG exceeded the US Market which returned 8.4% over the past year.
Price Volatility Vs. Market
How volatile is LHC Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 weeks ago | Simply Wall StIs Now The Time To Put LHC Group (NASDAQ:LHCG) On Your Watchlist?
1 month ago | Simply Wall StShould You Rely On LHC Group's (NASDAQ:LHCG) Earnings Growth?
2 months ago | Simply Wall StWhat Kind Of Share Price Volatility Should You Expect For LHC Group, Inc. (NASDAQ:LHCG)?
Is LHC Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: LHCG ($162.48) is trading below our estimate of fair value ($209.66)
Significantly Below Fair Value: LHCG is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: LHCG is poor value based on its PE Ratio (50.9x) compared to the Healthcare industry average (25.6x).
PE vs Market: LHCG is poor value based on its PE Ratio (50.9x) compared to the US market (16x).
Price to Earnings Growth Ratio
PEG Ratio: LHCG is poor value based on its PEG Ratio (2.3x)
Price to Book Ratio
PB vs Industry: LHCG is overvalued based on its PB Ratio (3.5x) compared to the US Healthcare industry average (3x).
How is LHC Group forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LHCG's forecast earnings growth (22% per year) is above the savings rate (2.2%).
Earnings vs Market: LHCG's earnings (22% per year) are forecast to grow faster than the US market (21.7% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: LHCG's revenue (8.6% per year) is forecast to grow slower than the US market (8.8% per year).
High Growth Revenue: LHCG's revenue (8.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LHCG's Return on Equity is forecast to be low in 3 years time (11.4%).
How has LHC Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: LHCG has high quality earnings.
Growing Profit Margin: LHCG's current net profit margins (4.7%) are higher than last year (3.8%).
Past Earnings Growth Analysis
Earnings Trend: LHCG's earnings have grown significantly by 28.2% per year over the past 5 years.
Accelerating Growth: LHCG's earnings growth over the past year (27.6%) is below its 5-year average (28.2% per year).
Earnings vs Industry: LHCG earnings growth over the past year (27.6%) exceeded the Healthcare industry 10.1%.
Return on Equity
High ROE: LHCG's Return on Equity (7.7%) is considered low.
How is LHC Group's financial position?
Financial Position Analysis
Short Term Liabilities: LHCG's short term assets ($439.5M) exceed its short term liabilities ($252.4M).
Long Term Liabilities: LHCG's short term assets ($439.5M) exceed its long term liabilities ($434.5M).
Debt to Equity History and Analysis
Debt Level: LHCG's debt to equity ratio (19.5%) is considered satisfactory.
Reducing Debt: LHCG's debt to equity ratio has increased from 14% to 19.5% over the past 5 years.
Debt Coverage: LHCG's debt is well covered by operating cash flow (25%).
Interest Coverage: LHCG's interest payments on its debt are well covered by EBIT (14.4x coverage).
What is LHC Group's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate LHCG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate LHCG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if LHCG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if LHCG's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of LHCG's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Keith Myers (60yo)
Mr. Keith G. Myers has been the Co-Founder, Chairman and Chief Executive Officer of LHC Group, Inc. since 1994 and serves as its President since December 31, 2019. Mr. Myers has been Director of Almost Fam ...
CEO Compensation Analysis
Compensation vs Market: Keith's total compensation ($USD4.66M) is below average for companies of similar size in the US market ($USD7.31M).
Compensation vs Earnings: Keith's compensation has been consistent with company performance over the past year.
|CFO & Treasurer||4.08yrs||US$3.41m||0.27% $13.8m|
|Executive VP & General Counsel||1.33yrs||US$862.17k||0.020% $1.0m|
|Executive VP and Chief Strategy & Innovation Officer||1.67yrs||US$1.02m||0.059% $3.0m|
|Consultant & Independent Director||19.92yrs||US$232.82k||0.10% $5.4m|
|Senior VP & Chief Accounting Officer||0.83yr||no data||0.0015% $78.0k|
|Chief Information Officer||0.42yr||no data||no data|
|Executive VP & Chief Administrative Officer||no data||no data||no data|
|Senior VP & Chief Compliance Officer||7.33yrs||no data||no data|
|Senior VP & Chief Communications Officer||no data||no data||no data|
Experienced Management: LHCG's management team is considered experienced (2.9 years average tenure).
|Consultant & Independent Director||19.92yrs||US$232.82k||0.10% $5.4m|
|Independent Director||18.83yrs||US$244.82k||0.096% $4.9m|
|Independent Director||2.5yrs||US$228.32k||0.021% $1.1m|
|Independent Director||2.5yrs||US$228.32k||0.18% $9.0m|
|Transitional Advisory Council||1.17yrs||US$164.95k||no data|
|Independent Director||5.75yrs||US$319.06k||0.039% $2.0m|
|Lead Independent Director||15.33yrs||US$260.82k||0.13% $6.7m|
|Independent Director||12.5yrs||US$235.82k||0.091% $4.7m|
|Member of Founder's Advisory Board||6.42yrs||no data||no data|
Experienced Board: LHCG's board of directors are considered experienced (9.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
LHC Group, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: LHC Group, Inc.
- Ticker: LHCG
- Exchange: NasdaqGS
- Founded: 1994
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$5.133b
- Shares outstanding: 31.59m
- Website: https://www.lhcgroup.com
Number of Employees
- LHC Group, Inc.
- 901 Hugh Wallis Road South
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|LH6||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Jun 2005|
|LHCG||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Jun 2005|
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company’s Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services. Its Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. The company’s Home and Community-Based Services segment offers services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand services to patients in their home or in a medical facility. Its Facility-Based Services segment serves patients suffering from respiratory failure, neuromuscular disorders, cardiac disorders, non-healing wounds, renal disorders, cancer, head and neck injuries, and mental disorders, as well as treats patients diagnosed with musculoskeletal impairments; and operates institutional pharmacy, a family health center, a rural health clinic, and a retail pharmacy, as well as offers physical therapy services. The company’s Healthcare Innovations (HCI) Services segment provides strategic health management services to Accountable Care Organizations. As of December 31, 2019, it operated 553 home health services locations, 110 hospice locations, 107 community-based service locations, 11 long-term acute care hospitals with 13 locations, and 10 HCI locations. The company was founded in 1994 and is based in Lafayette, Louisiana.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/05/28 02:45|
|End of Day Share Price||2020/05/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.